{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:12:53Z","timestamp":1760955173666},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,8,5]],"date-time":"2009-08-05T00:00:00Z","timestamp":1249430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s00404-009-1189-7","type":"journal-article","created":{"date-parts":[[2009,8,4]],"date-time":"2009-08-04T06:38:50Z","timestamp":1249367930000},"page":"539-543","source":"Crossref","is-referenced-by-count":6,"title":["Oral contraceptives alone and with spironolactone increase sCD40 ligand in PCOS patients"],"prefix":"10.1007","volume":"281","author":[{"given":"Levent","family":"Kebapcilar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oktay","family":"Bilgir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuneyt Eftal","family":"Taner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse Gul","family":"Kebapcilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didem L.","family":"Kozaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Alacacioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasar","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arif","family":"Yuksel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Sari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,5]]},"reference":[{"key":"1189_CR1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","volume":"333","author":"S Franks","year":"1995","unstructured":"Franks S (1995) Polycystic ovary syndrome. N Engl J Med 333:853\u2013861","journal-title":"N Engl J Med"},{"key":"1189_CR2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2003.10.005","volume":"172","author":"A Doring","year":"2004","unstructured":"Doring A, Frohlich M, Lowel H, Koenig W (2004) Third generation oral contraceptive use and cardiovascular risk factors. Atherosclerosis 172:281\u2013286","journal-title":"Atherosclerosis"},{"key":"1189_CR3","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","volume":"344","author":"JP Vandenbroucke","year":"2001","unstructured":"Vandenbroucke JP, Rosing J, Bloemenkamp KW, Middeldorp S, Helmerhorst FM, Bouma BN, Rosendaal FR (2001) Oral contraceptives and the risk of venous thrombosis. N Engl J Med 344:1527\u20131535","journal-title":"N Engl J Med"},{"key":"1189_CR4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/09513590802291824","volume":"24","author":"F Karakurt","year":"2008","unstructured":"Karakurt F, Gumus II, Bavbek N, Kargili A, Koca C, Selcoki Y, Ozbek M, Kosar A, Akcay A (2008) Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome. Gynecol Endocrinol 24:491\u2013497","journal-title":"Gynecol Endocrinol"},{"key":"1189_CR5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00404-008-0884-0","volume":"280","author":"L Kebapcilar","year":"2009","unstructured":"Kebapcilar L, Taner CE, Kebapcilar AG, Sari I (2009) High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome. Arch Gynecol Obstet 280:187\u2013193","journal-title":"Arch Gynecol Obstet"},{"key":"1189_CR6","doi-asserted-by":"crossref","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81:19\u201325","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"1189_CR7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000066348","volume":"25","author":"AI Yalcin","year":"2002","unstructured":"Yalcin AI, Dincer M, Aslan V, Gulbas Z (2002) Effect of spironolactone on impaired fibrinolysis of hypertensive patients. Kidney Blood Press Res 25:260\u2013264","journal-title":"Kidney Blood Press Res"},{"key":"1189_CR8","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1210\/jc.2003-030374","volume":"88","author":"P Sawathiparnich","year":"2003","unstructured":"Sawathiparnich P, Murphey LJ, Kumar S, Vaughan DE, Brown NJ (2003) Effect of combined AT1 receptor and aldosterone receptor antagonism on plasminogen activator inhibitor-1. J Clin Endocrinol Metab 88:3867\u20133873","journal-title":"J Clin Endocrinol Metab"},{"key":"1189_CR9","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S0021-9150(97)00309-2","volume":"137 Suppl","author":"F Mach","year":"1998","unstructured":"Mach F, Schonbeck U, Libby P (1998) CD40 signaling in vascular cells: a key role in atherosclerosis? Atherosclerosis 137 Suppl:S89\u2013S95","journal-title":"Atherosclerosis"},{"key":"1189_CR10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/01.CIR.0000028962.04520.01","volume":"106","author":"P Andr\u00e9","year":"2002","unstructured":"Andr\u00e9 P, Nannizzi-Alaimo L, Prasad SK, Phillips DR (2002) Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 106:896\u2013899","journal-title":"Circulation"},{"key":"1189_CR11","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1016\/j.fertnstert.2008.03.039","volume":"91","author":"M Oktem","year":"2009","unstructured":"Oktem M, Ozcimen EE, Uckuyu A, Esinler I, Pamuk B, Bayraktar N, Kulaksizoglu S, Zeyneloglu HB (2009) Polycystic ovary syndrome is associated with elevated plasma soluble CD40 ligand, a marker of coronary artery disease. Fertil Steril 91:2545\u20132550","journal-title":"Fertil Steril"},{"key":"1189_CR12","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1161\/hc4401.099447","volume":"104","author":"U Schonbeck","year":"2001","unstructured":"Schonbeck U, Varo N, Libby P, Buring J, Ridker PM (2001) Soluble CD40L and cardiovascular risk in women. Circulation 104:2266\u20132268","journal-title":"Circulation"},{"key":"1189_CR13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.cardiores.2006.05.015","volume":"71","author":"P Geraldes","year":"2006","unstructured":"Geraldes P, Gagnon S, Hadjadj S, Merhi Y, Sirois MG, Cloutier I, Tanguay JF (2006) Estradiol blocks the induction of CD40 and CD40L expression on endothelial cells and prevents neutrophil adhesion: an ER alpha-mediated pathway. Cardiovasc Res 71:566\u2013573","journal-title":"Cardiovasc Res"},{"key":"1189_CR14","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0889-857X(05)70178-2","volume":"26","author":"RG Lahita","year":"2000","unstructured":"Lahita RG (2000) Sex hormones and systemic lupus erythematosus. Rheum Dis Clin North Am 26:951\u2013968","journal-title":"Rheum Dis Clin North Am"},{"key":"1189_CR15","first-page":"2644","volume":"28","author":"V Rider","year":"2001","unstructured":"Rider V, Jones S, Evans M, Bassiri H, Afsar Z, Abdou NI (2001) Estrogen increases CD40 ligand expression in T cells from women with systemic lupus erythematosus. J Rheumatol 28:2644\u20132649","journal-title":"J Rheumatol"},{"key":"1189_CR16","first-page":"797","volume":"35","author":"NI Abdou","year":"2008","unstructured":"Abdou NI, Rider V, Greenwell C, Li X, Kimler BF (2008) Fulvestrant (Faslodex), an estrogen selective receptor downregulator, in therapy of women with systemic lupus erythematosus. Clinical, serologic, bone density, and T cell activation marker studies: a double-blind placebo-controlled trial. J Rheumatol 35:797","journal-title":"J Rheumatol"},{"key":"1189_CR17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2119\/2008-00026.Stice","volume":"14","author":"JP Stice","year":"2008","unstructured":"Stice JP, Knowlton AA (2008) Estrogen, NFkappaB, and the heat shock response. Mol Med 14:517\u2013527","journal-title":"Mol Med"},{"key":"1189_CR18","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1074\/jbc.271.7.3763","volume":"271","author":"AV Tsytsykova","year":"1996","unstructured":"Tsytsykova AV, Tsitsikov EN, Geha RS (1996) The CD40L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription. J Biol Chem 271:3763\u20133770","journal-title":"J Biol Chem"},{"key":"1189_CR19","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1182\/blood.V99.2.520","volume":"99","author":"AH Wagner","year":"2002","unstructured":"Wagner AH, Gebauer M, Pollok-Kopp B, Hecker M (2002) Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1. Blood 99:520\u2013525","journal-title":"Blood"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-009-1189-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-009-1189-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-009-1189-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T17:53:54Z","timestamp":1559066034000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-009-1189-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,5]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["1189"],"URL":"https:\/\/doi.org\/10.1007\/s00404-009-1189-7","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,5]]}}}